Skip to main content

Minerva Surgical, Inc. (UTRS)

NASDAQ: UTRS · IEX Real-Time Price · USD
5.86
0.06 (1.03%)
At close: Dec 3, 2021 4:00 PM
5.81
-0.05 (-0.85%)
After-hours:Dec 3, 2021 4:00 PM EST
Market Cap167.41M
Revenue (ttm)51.78M
Net Income (ttm)-42.74M
Shares Out28.57M
EPS (ttm)-1.50
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume178,031
Open5.90
Previous Close5.80
Day's Range4.68 - 6.32
52-Week Range4.68 - 10.37
Betan/a
AnalystsBuy
Price Target15.75 (+168.8%)
Earnings Daten/a

About UTRS

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. We have established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Our solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associa...

IndustryHealth Information Services
IPO DateOct 22, 2021
CEODavid M. Clapper
Employees139
Stock ExchangeNASDAQ
Ticker SymbolUTRS
Full Company Profile

Financial Performance

In 2020, UTRS's revenue was $37.77 million, an increase of 45.19% compared to the previous year's $26.01 million. Losses were -$18.26 million, -64.91% less than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for UTRS stock is "Buy." The 12-month stock price forecast is 15.75, which is an increase of 168.77% from the latest price.

Price Target
$15.75
(168.77% upside)
Analyst Consensus: Buy

News

Minerva Surgical, Inc. Third Quarter 2021 Financial Results

SANTA CLARA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a medical device company that develops therapeutic devices that treat abno...

1 day ago - GlobeNewsWire

Minerva Surgical to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference

SANTA CLARA, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that i...

2 weeks ago - GlobeNewsWire

Minerva Surgical Launches Educational Website for Women Living with Abnormal Uterine Bleeding

AUBandMe.com debuts at the American Association of Gynecologic Laparoscopists 50th Global Congress AUBandMe.com debuts at the American Association of Gynecologic Laparoscopists 50th Global Congress

2 weeks ago - GlobeNewsWire

Minerva Surgical Announces Closing of Initial Public Offering

SANTA CLARA, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Minerva Surgical), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced th...

1 month ago - GlobeNewsWire

Minerva Surgical Announces Pricing of Initial Public Offering

Minerva Surgical, Inc. (Minerva Surgical), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today...

1 month ago - PRNewswire

Minerva Surgical IPO Registration Document (S-1)

Minerva Surgical, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC